Letermovir

Letermovir is an antiviral medicine used to help prevent cytomegalovirus (CMV) infection after a stem cell (bone marrow) transplant from a donor in adults and children at least 6 months old and weighing at least 88 pounds (40 kg).

Specifications

Human
Injectable ,Oral
Commercial
Patent Evaluation Information
Pricing

FEATURED Products

Information not available
Information not available
View all products

Related Media

View All
lab vial icon

New Product Development

Where our FDA approved laboratory begins developing products, formulating and validating methods to ensure quality.

arrow icon
magnifier icon

Compliance Audits

Where we audit and champion our partner factories to exceed cGMP standards set by authorities.

arrow icon
forms icon

Regulatory Services

Where all submissions are filed with the knowledge and experience of our 550+ worldwide approvals on record.

arrow icon